Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Sci Total Environ ; 615: 632-642, 2018 Feb 15.
Article in English | MEDLINE | ID: mdl-28992490

ABSTRACT

Caffeine is an emerging contaminant considered to be an indicator of human contamination that has been widely detected in various aquatic systems, especially in continental waters. Nevertheless, the extent of its possible environmental impact is yet to be determined. This study determined the presence of caffeine, and evaluated the environmental hazard posed by this substance, in the "Rías Gallegas", a series of costal inlets in north-west Spain which are of great ecological value and in which fishing and bivalve farming, are a significant source of income. Caffeine was found to be present at concentrations higher than the limit of quantification (LOQ=3.07ngL-1) in 15 of the 23 samples analysed, with the highest seawater concentration being 857ngL-1 (the highest measured in seawater in Spain). Six out of 22 seawater samples resulted in a hazard quotient (HQ) from chronic exposure higher than 1 with the highest being 17.14, indicating a high probability of adverse effects in the aquatic environment. Environmental Exposure Distributions (EEDs) generated from a literature review of caffeine levels reported previously in four out of the five continents, showed that 28% of all seawater samples, and 69% of all estuary water samples where caffeine has ever been measured resulted in HQ>1 for chronic exposure. Further studies into the potential adverse effects that may arise from exposure to caffeine in aquatic systems are still required. Indeed, the need to gain a more in-depth understanding of the long-term ecotoxicological effects of caffeine is essential to ensure the quality of our health and environment.


Subject(s)
Caffeine/adverse effects , Environmental Monitoring , Seawater/analysis , Water Pollutants, Chemical/adverse effects , Spain
2.
PLoS One ; 8(11): e79670, 2013.
Article in English | MEDLINE | ID: mdl-24223991

ABSTRACT

Apoptosis inhibitor of macrophages (AIM), a scavenger protein secreted by tissue macrophages, is transcriptionally regulated by the nuclear receptor Liver X Receptor (LXR) and Retinoid X Receptor (RXR) heterodimer. Given that LXR exerts a protective immune response against M. tuberculosis, here we analyzed whether AIM is involved in this response. In an experimental murine model of tuberculosis, AIM serum levels peaked dramatically early after infection with M. tuberculosis, providing an in vivo biological link to the disease. We therefore studied the participation of AIM in macrophage response to M. tuberculosis in vitro. For this purpose, we used the H37Rv strain to infect THP-1 macrophages transfected to stably express AIM, thereby increasing infected macrophage survival. Furthermore, the expression of this protein enlarged foam cell formation by enhancing intracellular lipid content. Phagocytosis assays with FITC-labeled M. tuberculosis bacilli indicated that this protein was not involved in bacterial uptake; however, AIM expression decreased the number of intracellular cfus by up to 70% in bacterial killing assays, suggesting that AIM enhances macrophage mycobactericidal activity. Accordingly, M. tuberculosis-infected AIM-expressing cells upregulated the production of reactive oxygen species. Moreover, real-time PCR analysis showed increased mRNA levels of the antimicrobial peptides cathelicidin and defensin 4B. These increases were concomitant with greater cellular concentrations of the autophagy-related molecules Beclin 1 and LC3II, as well as enhanced acidification of mycobacterial phagosomes and LC3 co-localization. In summary, our data support the notion that AIM contributes to key macrophage responses to M. tuberculosis.


Subject(s)
Apoptosis Regulatory Proteins/metabolism , Autophagy , Mycobacterium tuberculosis/physiology , Receptors, Immunologic/metabolism , Animals , Antimicrobial Cationic Peptides/metabolism , Apoptosis Regulatory Proteins/blood , Apoptosis Regulatory Proteins/genetics , Bacterial Load , Cell Line , Cell Survival , Female , Gene Expression Regulation , Humans , Immunity, Innate , Interleukin-8/metabolism , Liver X Receptors , Macrophages/cytology , Macrophages/immunology , Macrophages/metabolism , Mice , Orphan Nuclear Receptors/metabolism , Reactive Oxygen Species/metabolism , Receptors, Immunologic/blood , Receptors, Immunologic/genetics , Receptors, Scavenger , beta-Defensins/metabolism , Cathelicidins
3.
Tuberculosis (Edinb) ; 93(6): 690-8, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24011631

ABSTRACT

The aim of this study was to evaluate the evolution and role of corded cell aggregation in Mycobacterium tuberculosis cultures according to growth time and conditions. Thus, in standard culture using aerated 7H9 Middlebrook broth supplemented with 0.05% Tween 80, a dramatic CFU decrease was observed at the end of the exponential phase. This phase was followed by a stable stationary phase that led to dissociation between the optical density (O.D.) and CFU values, together with the formation of opaque colonies in solid culture. Further analysis revealed that this was due to cording. Scanning electron microscopy showed that cording led to the formation of very stable coiled structures and corded cell aggregations which proved impossible to disrupt by any of the physical means tested. Modulation of cording with a high but non-toxic concentration of Tween 80 led to a slower growth rate, avoidance of a sudden drop-off to the stationary phase, the formation of weaker cording structures and the absence of opaque colonies, together with a lower survival at later time-points. An innovative automated image analysis technique has been devised to characterize the cording process. This analysis has led to important practical consequences for the elaboration of M. tuberculosis inocula and suggests the importance of biofilm formation in survival of the bacilli in the extracellular milieu.


Subject(s)
Cell Aggregation/physiology , Cord Factors/physiology , Mycobacterium tuberculosis/physiology , Biofilms , Colony Count, Microbial , Freezing , Image Processing, Computer-Assisted/methods , Microscopy, Electron, Scanning , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/growth & development , Mycobacterium tuberculosis/ultrastructure , Polysorbates/pharmacology , Stress, Physiological/physiology
4.
PLoS One ; 7(1): e29010, 2012.
Article in English | MEDLINE | ID: mdl-22235258

ABSTRACT

BACKGROUND: Evaluation of a quick and easy model to determine the intrinsic ability of clinical strains to generate active TB has been set by assuming that this is linked to the fitness of Mycobacterium tuberculosis strain at the innate phase of the infection. Thus, the higher the bacillary load, the greater the possibility of inducting liquefaction, and thus active TB, once the adaptive response is set. METHODOLOGY/PRINCIPAL FINDINGS: The virulence of seven clinical Mycobacterium tuberculosis strains isolated in Spain was tested by determining the bacillary concentration in the spleen and lung of mice at weeks 0, 1 and 2 after intravenous (IV) inoculation of 104 CFU, and by determining the growth in vitro until the stationary phase had been reached. Cord distribution automated analysis showed two clear patterns related to the high and low fitness in the lung after IV infection. This pattern was not seen in the in vitro fitness tests, which clearly favored the reference strain (H37Rv). Subsequent determination using a more physiological low-dose aerosol (AER) inoculation with 10² CFU showed a third pattern in which the three best values coincided with the highest dissemination capacity according to epidemiological data. CONCLUSIONS/SIGNIFICANCE: The fitness obtained after low dose aerosol administration in the presence of the innate immune response is the most predictive factor for determining the virulence of clinical strains. This gives support to a mechanism of the induction of active TB derived from the dynamic hypothesis of latent tuberculosis infection.


Subject(s)
Immunity, Innate , Mycobacterium tuberculosis/physiology , Mycobacterium tuberculosis/pathogenicity , Tuberculosis/immunology , Tuberculosis/microbiology , Adult , Aerosols , Animals , Child, Preschool , Female , Humans , Laboratories , Lung/immunology , Lung/microbiology , Male , Mice , Middle Aged , Models, Biological , Mycobacterium tuberculosis/isolation & purification , Spleen/immunology , Spleen/microbiology , Tuberculosis/epidemiology , Virus Latency
5.
PLoS One ; 6(5): e20404, 2011.
Article in English | MEDLINE | ID: mdl-21647222

ABSTRACT

The prophylactic capacity of the RUTI® vaccine, based on fragmented cells of Mycobacterium tuberculosis, has been evaluated in respect to aerosol challenge with virulent bacilli. Subcutaneous vaccination significantly reduced viable bacterial counts in both lungs and spleens of C57Bl mice, when challenged 4 weeks after vaccination. RUTI® protected the spleen less than BCG. Following a 9 month vaccination-challenge interval, protection was observed for the lungs, but not for the spleen. Survival of infected guinea pigs was prolonged by vaccination given 5 weeks before challenge. Inoculations of RUTI® shortly after infection significantly reduced the viable bacterial counts in the lungs, when compared with infected control mice. Thus, vaccination by RUTI® has potential for both the prophylaxis and immunotherapy of tuberculosis.


Subject(s)
Bacterial Vaccines/immunology , Mycobacterium tuberculosis/cytology , Mycobacterium tuberculosis/immunology , Tuberculosis/prevention & control , Vaccination/methods , Animals , Female , Guinea Pigs , Mice , Time Factors
6.
PLoS One ; 5(4): e10030, 2010 Apr 06.
Article in English | MEDLINE | ID: mdl-20386605

ABSTRACT

A transthoracic infection involving a low dose of Mycobacterium tuberculosis has been used to establish a new model of infection in minipigs. The 20-week monitoring period showed a marked Th1 response and poor humoral response for the whole infection. A detailed histopathological analysis was performed after slicing the formalin-fixed whole lungs of each animal. All lesions were recorded and classified according to their microscopic aspect, their relationship with the intralobular connective network and their degree of maturity in order to obtain a dissemination ratio (DR) between recent and old lesions. CFU counts and evolution of the DR with time showed that the proposed model correlated with a contained infection, decreasing from week 9 onwards. These findings suggest that the infection induces an initial Th1 response, which is followed by local fibrosis and encapsulation of the granulomas, thereby decreasing the onset of new lesions. Two therapeutic strategies were applied in order to understand how they could influence the model. Thus, chemotherapy with isoniazid alone helped to decrease the total number of lesions, despite the increase in DR after week 9, with similar kinetics to those of the control group, whereas addition of a therapeutic M. tuberculosis fragment-based vaccine after chemotherapy increased the Th1 and humoral responses, as well as the number of lesions, but decreased the DR. By providing a local pulmonary structure similar to that in humans, the mini-pig model highlights new aspects that could be key to a better understanding tuberculosis infection control in humans.


Subject(s)
Fibrosis/pathology , Granuloma/pathology , Tuberculosis/therapy , Animals , Bacterial Vaccines/pharmacology , Disease Models, Animal , Immunity, Humoral/drug effects , Isoniazid/pharmacology , Mycobacterium tuberculosis , Swine , Swine, Miniature , Th1 Cells/immunology , Tuberculosis/pathology
7.
Antimicrob Agents Chemother ; 54(5): 2262-4, 2010 May.
Article in English | MEDLINE | ID: mdl-20160054

ABSTRACT

Murine models of Mycobacterium tuberculosis infection are essential tools in drug discovery. Here we describe a fast standardized 9-day acute assay intended to measure the efficacy of drugs against M. tuberculosis growing in the lungs of immunocompetent mice. This assay is highly reproducible, allows good throughput, and was validated for drug lead optimization using isoniazid, rifampin, ethambutol, pyrazinamide, linezolid, and moxifloxacin.


Subject(s)
Antitubercular Agents/pharmacology , Disease Models, Animal , Drug Discovery , Mice, Inbred C57BL , Tuberculosis, Pulmonary/drug therapy , Acetamides/pharmacology , Animals , Aza Compounds/pharmacology , Ethambutol/pharmacology , Fluoroquinolones , Immunocompetence , Inhalation Exposure , Isoniazid/pharmacology , Linezolid , Mice , Moxifloxacin , Oxazolidinones/pharmacology , Pyrazinamide/pharmacology , Quinolines/pharmacology , Reproducibility of Results , Rifampin/pharmacology , Tuberculosis, Pulmonary/immunology
8.
Tuberculosis (Edinb) ; 89(2): 175-82, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19110471

ABSTRACT

The chronic phase of Mycobacterium tuberculosis infection in mouse experimental models is characterized by the accumulation of foamy macrophages (FM)--which shape the outer ring of the granuloma - in the alveolar spaces, as detected in paraffin-embedded tissues stained with hematoxylin-eosin. In this study, the use of semi- and ultra-thin sections offers more detailed information about the origin of FM both in mouse and guinea-pig experimental models. Lipid bodies (LB) are present in macrophages from the beginning of infection and accumulate in the chronic phase. LB progress from an early (ELB) to a late (LLB) stage, defined according to their progressive capacity to generate cholesterol crystals, resembling atherosclerotic lesions. FM arise from massive accumulation of LLB. Electronic microscopy reveals intracellular lipophilic inclusions (ILIs) in those M. tuberculosis bacilli inside FM. It is our hypothesis that the accumulation of lipids in M. tuberculosis concomitant to the establishment of the non-replicating state prepares the bacilli for future reactivation and for facing future stressful environments.


Subject(s)
Foam Cells/ultrastructure , Granuloma/pathology , Tuberculosis, Pulmonary/pathology , Animals , Cholesterol/metabolism , Chronic Disease , Disease Models, Animal , Disease Progression , Female , Foam Cells/metabolism , Granuloma/metabolism , Guinea Pigs , Lung/metabolism , Lung/pathology , Macrophages, Alveolar/metabolism , Macrophages, Alveolar/ultrastructure , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Microscopy, Electron , Necrosis/metabolism , Necrosis/pathology , Phagosomes/ultrastructure , Tuberculosis, Pulmonary/metabolism
9.
Clin Vaccine Immunol ; 15(11): 1742-4, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18827194

ABSTRACT

Gamma interferon responses of spleen cells in mice were examined during postchemotherapy relapse of intraperitoneally induced latent tuberculous infection. The mycobacterial extract RUTI, which prevented the relapse, significantly enhanced the immune responses to secreted and structural recombinant mycobacterial antigens, suggesting that RUTI-mediated protection was mediated by activated T cells.


Subject(s)
Immunotherapy/methods , Interferon-gamma/biosynthesis , Leukocytes, Mononuclear/immunology , Spleen/immunology , Tuberculosis/therapy , Animals , Mice , Recurrence
10.
J Exp Med ; 205(9): 2075-84, 2008 Sep 01.
Article in English | MEDLINE | ID: mdl-18695004

ABSTRACT

D6 is a decoy and scavenger receptor for inflammatory CC chemokines. D6-deficient mice were rapidly killed by intranasal administration of low doses of Mycobacterium tuberculosis. The death of D6(-/-) mice was associated with a dramatic local and systemic inflammatory response with levels of M. tuberculosis colony-forming units similar to control D6-proficient mice. D6-deficient mice showed an increased numbers of mononuclear cells (macrophages, dendritic cells, and CD4 and CD8 T lymphocytes) infiltrating inflamed tissues and lymph nodes, as well as abnormal increased concentrations of CC chemokines (CCL2, CCL3, CCL4, and CCL5) and proinflammatory cytokines (tumor necrosis factor alpha, interleukin 1beta, and interferon gamma) in bronchoalveolar lavage and serum. High levels of inflammatory cytokines in D6(-/-) infected mice were associated with liver and kidney damage, resulting in both liver and renal failure. Blocking inflammatory CC chemokines with a cocktail of antibodies reversed the inflammatory phenotype of D6(-/-) mice but led to less controlled growth of M. tuberculosis. Thus, the D6 decoy receptor plays a key role in setting the balance between antimicrobial resistance, immune activation, and inflammation in M. tuberculosis infection.


Subject(s)
Anti-Infective Agents/pharmacology , Drug Resistance, Bacterial , Immune System , Inflammation , Mycobacterium tuberculosis/metabolism , Receptors, CCR10/physiology , Animals , Interferon-gamma/biosynthesis , Interleukin-1beta/biosynthesis , Lymph Nodes/microbiology , Mice , Mice, Transgenic , Models, Biological , Phenotype , Tumor Necrosis Factor-alpha/biosynthesis , Chemokine Receptor D6
11.
Clin Vaccine Immunol ; 15(8): 1229-37, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18524883

ABSTRACT

RUTI is a therapeutic vaccine that is generated from detoxified and liposomed Mycobacterium tuberculosis cell fragments that has demonstrated its efficacy in the control of bacillus reactivation after short-term chemotherapy. The aim of this study was to characterize the cellular immune response generated after the therapeutic administration of RUTI and to corroborate the lack of toxicity of the vaccine. Mouse and guinea pig experimental models were infected with a low-dose M. tuberculosis aerosol. RUTI-treated animals showed the lowest bacillary load in both experimental models. RUTI also decreased the percentage of pulmonary granulomatous infiltration in the mouse and guinea pig models. This was not the case after Mycobacterium bovis BCG treatment. Cellular immunity was studied through the characterization of the intracellular gamma interferon (IFN-gamma)-producing cells after the splenocytes' stimulation with M. tuberculosis-specific structural and growth-related antigens. Our data show that the difference between the therapeutic administration of BCG and RUTI resides mainly in the stronger activation of IFN-gamma(+) CD4(+) cells and CD8(+) cells against tuberculin purified protein derivative, ESAT-6, and Ag85B that RUTI generates. Both vaccines also triggered a specific immune response against the M. tuberculosis structural antigens Ag16kDa and Ag38kDa and a marked mRNA expression of IFN-gamma, tumor necrosis factor, interleukin-12, inducible nitric oxide synthase, and RANTES in the lung. The results show that RUTI's therapeutic effect is linked not only to the induction of a Th1 response but also to the stimulation of a quicker and stronger specific immunity against structural and growth-related antigens that reduces both the bacillary load and the pulmonary pathology.


Subject(s)
Antigens, Bacterial/immunology , Antitubercular Agents , Mycobacterium tuberculosis/immunology , T-Lymphocytes/immunology , Tuberculosis Vaccines , Tuberculosis, Pulmonary , Animals , Antitubercular Agents/administration & dosage , Antitubercular Agents/therapeutic use , BCG Vaccine/administration & dosage , BCG Vaccine/immunology , Female , Guinea Pigs , Humans , Interferon-gamma/metabolism , Isoniazid/administration & dosage , Isoniazid/therapeutic use , Liposomes/administration & dosage , Liposomes/therapeutic use , Mice , Mice, Inbred C57BL , Rifampin/administration & dosage , Rifampin/analogs & derivatives , Rifampin/therapeutic use , Specific Pathogen-Free Organisms , Time Factors , Treatment Outcome , Tuberculosis Vaccines/administration & dosage , Tuberculosis Vaccines/therapeutic use , Tuberculosis, Pulmonary/drug therapy , Tuberculosis, Pulmonary/immunology , Tuberculosis, Pulmonary/therapy
12.
Microbes Infect ; 8(5): 1252-9, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16702016

ABSTRACT

We investigated the protective role of immune-sera against reactivation of Mycobacterium tuberculosis infection in SCID mice and found that passive immunization with sera obtained from mice treated with detoxified M. tuberculosis extracts (delivered in liposomes in a composition known as RUTI) exerted significant protection. Our SCID mouse model consisted of aerosol infection by M. tuberculosis, followed by 3 to 8weeks of chemotherapy with isoniazid+rifampicin (INH+RIF) (25 and 10mg/kg, respectively). After infection and antibiotic administration, two groups of mice were treated for up to 10weeks with intraperitoneal passive immunization using hyperimmune serum (HS) obtained from mice infected with M. tuberculosis, treated with chemotherapy (INH+RIF) for 8weeks and inoculated with RUTI (HS group) or with normal serum (CT group). Significant differences were found between HS and CT groups in the number of bacilli in the lungs (3.68+/-2.02 vs. 5.72+/-1.41log(10) c.f.u.), extent of pulmonary granulomatomous infiltration (10.33+/-0.67 vs. 31.2+/-1.77%), and percentage of animals without pulmonary abscesses (16.7% vs. 45.5%). These data strongly suggest a protective role of specific antibodies against lung dissemination of M. tuberculosis infection.


Subject(s)
Immune Sera/administration & dosage , Immunization, Passive , Mycobacterium tuberculosis/immunology , Tuberculosis/prevention & control , Animals , Antibodies, Bacterial/administration & dosage , Antibodies, Bacterial/immunology , Antitubercular Agents/therapeutic use , Disease Models, Animal , Female , Humans , Immune Sera/immunology , Isoniazid/therapeutic use , Lung/microbiology , Mice , Mice, Inbred DBA , Mice, SCID , Rifampin/therapeutic use , Secondary Prevention , Specific Pathogen-Free Organisms , Tuberculosis/drug therapy , Tuberculosis/immunology , Tuberculosis/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...